Hendrik Peter Scholl

CIK: 0002113223

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)21 (95.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (4.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BLTE

BELITE BIO, INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (22 total)

BLTE
BELITE BIO, INC
Oct 1, 2026
Sale(S)
Indirect
12 shares at avg. $168.21$2K
BLTE
BELITE BIO, INC
Oct 1, 2026
Sale(S)
Indirect
14 shares at avg. $169.36$2K
BLTE
BELITE BIO, INC
Oct 1, 2026
Sale(S)
Indirect
2 shares at avg. $170.02$340.04
BLTE
BELITE BIO, INC
Oct 1, 2026
Sale(S)
Indirect
24 shares at avg. $164.64$4K
BLTE
BELITE BIO, INC
Oct 1, 2026
Sale(S)
Indirect
120 shares at avg. $165.49$20K
BLTE
BELITE BIO, INC
Oct 1, 2026
Sale(S)
Indirect
50 shares at avg. $166.44$8K
BLTE
BELITE BIO, INC
Oct 1, 2026
Sale(S)
Indirect
200 shares at avg. $163.63$33K
BLTE
BELITE BIO, INC
Oct 1, 2026
Sale(S)
Indirect
78 shares at avg. $167.59$13K
BLTE
BELITE BIO, INC
Jun 18, 2026
Sale(S)
Indirect
96 shares at avg. $143.90$14K
BLTE
BELITE BIO, INC
Jun 18, 2026
Sale(S)
Indirect
3.7K shares at avg. $144.66$542K
BLTE
BELITE BIO, INC
Jun 18, 2026
Sale(S)
Indirect
4.9K shares at avg. $145.43$707K
BLTE
BELITE BIO, INC
Jun 18, 2026
Sale(S)
Indirect
1.2K shares at avg. $146.24$175K
BLTE
BELITE BIO, INC
Jun 18, 2026
Sale(S)
Indirect
96 shares at avg. $147.11$14K
BLTE
BELITE BIO, INC
Jun 16, 2026
Sale(S)
Indirect
540 shares at avg. $140.58$76K
BLTE
BELITE BIO, INC
Jun 16, 2026
Sale(S)
Indirect
2.1K shares at avg. $137.61$283K
BLTE
BELITE BIO, INC
Jun 16, 2026
Sale(S)
Indirect
784 shares at avg. $138.18$108K
BLTE
BELITE BIO, INC
Jun 16, 2026
Sale(S)
Indirect
3.1K shares at avg. $139.57$438K
BLTE
BELITE BIO, INC
Jun 16, 2026
Sale(S)
Indirect
100 shares at avg. $141.83$14K
BLTE
BELITE BIO, INC
Jun 16, 2026
Sale(S)
Indirect
450 shares at avg. $142.20$64K
BLTE
BELITE BIO, INC
Jun 16, 2026
Sale(S)
Indirect
1.9K shares at avg. $143.55$272K
BLTE
BELITE BIO, INC
Jun 16, 2026
Sale(S)
Indirect
1K shares at avg. $145.02$150K
BLTE
BELITE BIO, INC
Apr 21, 2026
Other(J)
Stock Option (right to buy)
Indirect
10K shares-

		Type	Shares	Price		Ownership
Oct 1, 2026	BLTE BELITE BIO, INC	Sale(S)	12	$168.21	$2,019	Indirect
Oct 1, 2026	BLTE BELITE BIO, INC	Sale(S)	14	$169.36	$2,371	Indirect
Oct 1, 2026	BLTE BELITE BIO, INC	Sale(S)	2	$170.02	$340	Indirect
Oct 1, 2026	BLTE BELITE BIO, INC	Sale(S)	24	$164.64	$3,951	Indirect
Oct 1, 2026	BLTE BELITE BIO, INC	Sale(S)	120	$165.49	$19,859	Indirect
Oct 1, 2026	BLTE BELITE BIO, INC	Sale(S)	50	$166.44	$8,322	Indirect
Oct 1, 2026	BLTE BELITE BIO, INC	Sale(S)	200	$163.63	$32,725	Indirect
Oct 1, 2026	BLTE BELITE BIO, INC	Sale(S)	78	$167.59	$13,072	Indirect
Jun 18, 2026	BLTE BELITE BIO, INC	Sale(S)	96	$143.90	$13,814	Indirect
Jun 18, 2026	BLTE BELITE BIO, INC	Sale(S)	3,748	$144.66	$542,192	Indirect
Jun 18, 2026	BLTE BELITE BIO, INC	Sale(S)	4,861	$145.43	$706,959	Indirect
Jun 18, 2026	BLTE BELITE BIO, INC	Sale(S)	1,199	$146.24	$175,348	Indirect
Jun 18, 2026	BLTE BELITE BIO, INC	Sale(S)	96	$147.11	$14,123	Indirect
Jun 16, 2026	BLTE BELITE BIO, INC	Sale(S)	540	$140.58	$75,915	Indirect
Jun 16, 2026	BLTE BELITE BIO, INC	Sale(S)	2,054	$137.61	$282,641	Indirect
Jun 16, 2026	BLTE BELITE BIO, INC	Sale(S)	784	$138.18	$108,331	Indirect
Jun 16, 2026	BLTE BELITE BIO, INC	Sale(S)	3,140	$139.57	$438,260	Indirect
Jun 16, 2026	BLTE BELITE BIO, INC	Sale(S)	100	$141.83	$14,183	Indirect
Jun 16, 2026	BLTE BELITE BIO, INC	Sale(S)	450	$142.20	$63,988	Indirect
Jun 16, 2026	BLTE BELITE BIO, INC	Sale(S)	1,897	$143.55	$272,314	Indirect
Jun 16, 2026	BLTE BELITE BIO, INC	Sale(S)	1,035	$145.02	$150,097	Indirect
Apr 21, 2026	BLTE BELITE BIO, INC	Other(J) Stock Option (right to buy)	10,000	-	-	Indirect

1-22 of 22 transactions

About Scholl Hendrik Peter

Scholl Hendrik Peter (SEC CIK 0002113223) files insider reports with the SEC as Chief Medical Officer of BELITE BIO, INC (BLTE).

Signal8 holds 5 ownership filings by Scholl Hendrik Peter (1 Form 3, 4 Form 4), filed between Mar 18, 2026 and Oct 5, 2026. Those filings report 22 transactions, from Apr 21, 2026 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Scholl Hendrik Peter's filings is in ZUG.

Recent filings by Scholl Hendrik Peter

Oct 1, 2026: Open-market sales of BLTE shares (8 lines, Form 4, code S).
Jun 18, 2026: Open-market sales of BLTE shares (5 lines, Form 4, code S).
Jun 16, 2026: Open-market sales of BLTE shares (8 lines, Form 4, code S).
Apr 21, 2026: Other transaction of BLTE derivative securities (Form 4, code J).

Other insiders filing for BELITE BIO, INC (BLTE)

Chuang Hao-Yuan, Chief Financial Officer
Lin Yu-Hsin, Chief Executive Officer
Chen Wan-Shan, Director
MATA NATHAN L., Chief Scientific Officer
Chen Xiao-Hui, Director
Longo John Michael, Director

How to read Form 4 transaction codes